Siolta Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Allergic Disease Onset Prevention Study
Phase 1
Active, not recruiting
- Conditions
- Atopic DermatitisType 1 Hypersensitivity
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Siolta Therapeutics, Inc.
- Target Recruit Count
- 264
- Registration Number
- NCT05003804
- Locations
- 🇺🇸
University of Arizona Health Sciences, Tucson, Arizona, United States
🇺🇸Arkansas Children's Research Institute, Little Rock, Arkansas, United States
🇺🇸UCLA Health, Los Angeles, California, United States
A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy
Phase 1
- Conditions
- Atopic Immunoglobulin E-Mediated Allergic Disorder
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Siolta Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03819881
- Locations
- 🇺🇸
Bensch Clinical Research LLC, Stockton, California, United States
🇺🇸Orange County Research Center, Tustin, California, United States
News
No news found